Recap: Arcus Biosciences Q3 Earnings

Comments
Loading...

Arcus Biosciences RCUS reported its Q3 earnings results on Monday, November 8, 2021 at 04:10 PM.

Here's what investors need to know about the announcement.

Earnings

Arcus Biosciences their estimated earnings by 2.78%, reporting an EPS of $-1.11 versus an estimate of $-1.08, which did not surprise analysts.

Revenue was up $55,069,000 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.21, which was followed by a 10.56% drop in the share price the next day.

Here's a look at Arcus Biosciences's past performance:

 

Quarter Q2 2021 Q1 2021 Q4 2020 Q3 2020
EPS Estimate -0.88 -0.84 -0.75 0.05
EPS Actual -1.09 -1.08 -0.82 0.03
Revenue Estimate 13.05M 13.34M 7.93M 48.15M
Revenue Actual 9.46M 9.46M 9.49M 64.53M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

RCUS Logo
RCUSArcus Biosciences Inc
$9.68-0.26%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum9.27
Growth87.29
Quality-
Value64.07
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: